INZY שווי מלא של הפעילות העסקית Inozyme Pharma

This chart of the asset value for Inozyme Pharma, Inc. (INZY), which stands at , demonstrates the position of the developer of drugs for rare pathologies. The stability of the R&D staff and the absence of employee turnover ensure research progress. The business relies on partnerships with scientists to combat tissue calcification and minimizes risks by creating therapies for different age groups.

For Inozyme Pharma, Inc. (INZY), which lacks commercial revenue and is utilizing reserves for R&D, this metric reflects the actual acquisition cost of the business accounting for available cash. By analyzing the enterprise value indicator, an investor sees the sum of market capitalization and net debt, allowing for an assessment of the company's actual financial burden during the absence of operating revenue.